Alice Egerton, PhD, discusses a study which found that symptom improvements in people with treatment-resistant schizophrenia who switch to clozapine may be related to reductions in glutamate in the caudate nucleus.
In this video, Leslie Citrome, MD, MPH, discusses the use of long-acting injectable antipsychotics in the treatment of schizophrenia and bipolar disorder.